Wang Genwang, Pang Yu, Li Nan, Hui Yongfeng, Jin Dong
Department of Hepatobiliary Surgery, General Hospital of Ningxia Medical University, No. 804 Shengli Street, Yinchuan, 750004, China.
Intra Day Ward, General Hospital of Ningxia Medical University, Yinchuan, 750004, China.
Discov Oncol. 2025 Apr 18;16(1):561. doi: 10.1007/s12672-025-02324-6.
CXCR7 (ACKR3) has been well-supported as a promoter of growth and metastasis in hepatocellular carcinoma (HCC). Both CXCR7 and Hippo signaling play roles in organ development. We aimed to verify the involvement of Hippo-YAP signaling in CXCR7-regulated HCC proliferation, migration, and invasion.
HCCLM3 cells were transfected with si-CXCR7, pcDNA-CXCR7, or related control RNA/empty vector. Cell proliferation was assessed using the Cell Counting Kit-8 (CCK-8), and mRNA and protein levels were measured via quantitative real-time PCR (qPCR) and Western blotting. Colony formation assays were conducted to evaluate proliferation capacity, and Transwell assays were used to assess invasion and migration. Transcriptome data from the TCGA-LIHC dataset were analyzed to investigate the potential effects of CXCR7 in HCC.
si-CXCR7 inhibited cell proliferation in HCCLM3 cells, while pcDNA-CXCR7 promoted it. Migration and invasion were suppressed by si-CXCR7 but enhanced by pcDNA-CXCR7. Patients with higher CXCR7 expression in the TCGA-LIHC dataset had lower overall survival rates and increased gene transcription. The CXCR7-high expressing samples were characterized by the activation of several pathways, including PI3K-AKT signaling, calcium signaling, and the Hippo signaling pathway. si-CXCR7 reduced the relative protein levels of Gαq/11 and GαS while increasing phosphorylated LATS and phosphorylated YAP. Opposite trends in these proteins were observed with pcDNA-CXCR7. Finally, the inhibitory effects of si-CXCR7 on cell proliferation, migration, and invasion were reversed by the YAP inhibitor verteporfin.
We suggest that CXCR7 promotes the growth and metastasis of HCC cells, at least in part, by inactivating the Hippo-YAP signaling pathway.
CXCR7(ACKR3)作为肝细胞癌(HCC)生长和转移的促进因子已得到充分证实。CXCR7和Hippo信号通路在器官发育中均发挥作用。我们旨在验证Hippo-YAP信号通路是否参与CXCR7调控的肝癌细胞增殖、迁移和侵袭过程。
用si-CXCR7、pcDNA-CXCR7或相关对照RNA/空载体转染HCCLM3细胞。使用细胞计数试剂盒-8(CCK-8)评估细胞增殖情况,并通过定量实时PCR(qPCR)和蛋白质免疫印迹法检测mRNA和蛋白质水平。进行集落形成试验以评估增殖能力,采用Transwell试验评估侵袭和迁移能力。分析来自TCGA-LIHC数据集的转录组数据,以研究CXCR7在肝癌中的潜在作用。
si-CXCR7抑制HCCLM3细胞的增殖,而pcDNA-CXCR7则促进其增殖。si-CXCR7抑制迁移和侵袭,而pcDNA-CXCR7则增强迁移和侵袭。在TCGA-LIHC数据集中,CXCR7表达较高的患者总生存率较低,基因转录增加。CXCR7高表达样本的特征是多种信号通路的激活,包括PI3K-AKT信号通路、钙信号通路和Hippo信号通路。si-CXCR7降低了Gαq/11和GαS的相对蛋白水平,同时增加了磷酸化LATS和磷酸化YAP的水平。pcDNA-CXCR7处理后这些蛋白呈现相反的变化趋势。最后,YAP抑制剂维替泊芬逆转了si-CXCR7对细胞增殖、迁移和侵袭的抑制作用。
我们认为CXCR7至少部分通过使Hippo-YAP信号通路失活来促进肝癌细胞的生长和转移。